{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:53:15Z","timestamp":1782924795737,"version":"3.54.5"},"reference-count":86,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":180,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.06.046","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T04:01:53Z","timestamp":1625112113000},"page":"3908-3921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children"],"prefix":"10.34133","volume":"19","author":[{"given":"Huan","family":"Gao","sequence":"first","affiliation":[{"name":"Clinical Data Center, Guangdong Provincial People's Hospital\/Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ni","sequence":"additional","affiliation":[{"name":"Ping An Technology, No. 20 Keji South 12 Road, Shen Zhen 518063, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Mo","sequence":"additional","affiliation":[{"name":"School of Information Management, Wuhan University, Wuhan 430072, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dantong","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Data Center, Guangdong Provincial People's Hospital\/Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Psychology, School of Public Health, Southern Medical University, Guangzhou,510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, No. 9 Jinsui Road, Guangzhou 510623, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Huang","sequence":"additional","affiliation":[{"name":"Clinical Data Center, Guangdong Provincial People's Hospital\/Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjian","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Data Center, Guangdong Provincial People's Hospital\/Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ping An Technology, No. 20 Keji South 12 Road, Shen Zhen 518063, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, No. 9 Jinsui Road, Guangzhou 510623, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Information Management, Wuhan University, Wuhan 430072, Hubei, China"},{"name":"Institute of Pediatrics, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, No. 9 Jinsui Road, Guangzhou 510623, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Liang","sequence":"additional","affiliation":[{"name":"Clinical Data Center, Guangdong Provincial People's Hospital\/Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.278"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00050-2"},{"key":"e_1_3_5_4_2","unstructured":"Jon Baio E Wiggins L Christensen DL Maenner MJ Daniels J Warren Z: Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years \u2014 Autism and Developmental Disabilities Monitoring Network 11 Sites United States 2014. Morbidity and Mortality Weekly Report (MMWR) 2018."},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000132"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0037-1602823","article-title":"Drug treatments for core symptoms of autism spectrum disorder: unmet needs and future directions","volume":"15","author":"Mazzone L.","year":"2017","unstructured":"Mazzone L., Giovagnoli G., Siracusano M., Postorino V. and Curatolo P.: Drug treatments for core symptoms of autism spectrum disorder: unmet needs and future directions. J Pediatr Neurol 2017; 15: 134.","journal-title":"J Pediatr Neurol"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.24612"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1468"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos R.A.","year":"2016","unstructured":"Hodos R.A., Kidd B.A., Shameer K., Readhead B.P. and Dudley J.T.: In silico methods for drug repurposing and pharmacology. Wiley Interdip Rev Syst Biol Med 2016; 8: 186.","journal-title":"Wiley Interdip Rev Syst Biol Med"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2044"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PPO.0000000000000370","article-title":"Transcriptome signature reversion as a method to reposition drugs against cancer for precision oncology","volume":"25","author":"Koudijs K.K.M.","year":"2019","unstructured":"Koudijs K.K.M., Terwisscha van Scheltinga A.G.T., B\u00f6hringer S., Schimmel K.J.M. and Guchelaar H.-J.: Transcriptome signature reversion as a method to reposition drugs against cancer for precision oncology. Cancer J 2019; 25: 116.","journal-title":"Cancer J"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002648","article-title":"Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease","volume":"3","author":"Dudley J.T.","year":"2011","unstructured":"Dudley J.T., Sirota M., Shenoy M., Pai R.K., Roedder S., Chiang A.P. et al: Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 2011; 3. 96ra76-96ra76.","journal-title":"Sci Transl Med"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4618"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3992"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003523"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature20612"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2918"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12911-017-0449-x","article-title":"Network mirroring for drug repositioning","volume":"17","author":"Park S.","year":"2017","unstructured":"Park S., Lee D.G. and Shin H.: Network mirroring for drug repositioning. BMC Med Inf Decis Making 2017; 17: 55.","journal-title":"BMC Med Inf Decis Making"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.87","article-title":"Altered expression of histamine signaling genes in autism spectrum disorder","volume":"7","author":"Wright C.","year":"2017","unstructured":"Wright C., Shin J.H., Rajpurohit A., Deep-Soboslay A., Collado-Torres L., Brandon N.J. et al: Altered expression of histamine signaling genes in autism spectrum disorder. Transl Psychiat 2017; 7. e1126.","journal-title":"Transl Psychiat"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002558"},{"key":"e_1_3_5_22_2","first-page":"1103","article-title":"Conserved expression of lincRNA during human and macaque prefrontal cortex development and maturation","volume":"20","author":"He Z.","year":"2014","unstructured":"He Z., Bammann H., Han D., Xie G. and Khaitovich P.: Conserved expression of lincRNA during human and macaque prefrontal cortex development and maturation. Palliative Med 2014; 20: 1103.","journal-title":"Palliative Med"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","unstructured":"Li J Shi M Ma Z Zhao S Euskirchen G Ziskin J Urban A Hallmayer J Snyder M: Integrated systems analysis reveals a molecular network underlying autism spectrum disorders. Mol Syst Biol 2014.","DOI":"10.15252\/msb.20145487"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","unstructured":"Anthony M Bolger Marc Lohse Bjoern Usadel: Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (Oxford England) 2014.","DOI":"10.1093\/bioinformatics\/btu170"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","unstructured":"Trapnell C Pachter L Salzberg SL: TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009.","DOI":"10.1093\/bioinformatics\/btp120"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","author":"Anders S.","year":"2015","unstructured":"Anders S., Pyl T.P. and Huber W.: HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 2015; .","journal-title":"Bioinformatics"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"e_1_3_5_28_2","unstructured":"Jeffrey T Leek W Evan Johnson Hilary S Parker Andrew: The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (Oxford England) 2012."},{"key":"e_1_3_5_29_2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder P.","year":"2008","unstructured":"Langfelder P. and Horvath S.: WGCNA: an R package for weighted correlation network analysis. BMC Bioinf 2008; 9.","journal-title":"BMC Bioinf"},{"key":"e_1_3_5_30_2","first-page":"139","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson M.D.","year":"2010","unstructured":"Robinson M.D., McCarthy D.J. and Smyth G.K.: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Biogeoences 2010; 26: 139.","journal-title":"Biogeoences"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2392-4-36"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","unstructured":"Xu LM Li JR Huang Y Zhao M Tang X Wei L. AutismKB: an evidence-based knowledgebase of autism genetics. Nucleic Acids Res 2012 40(Database issue):D1016-D1022.","DOI":"10.1093\/nar\/gkr1145"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart D.S.","year":"2006","unstructured":"Wishart D.S.: DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucl Acids Res 2006; 34: D668.","journal-title":"Nucl Acids Res"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","unstructured":"A GH Christopher H Gerome B. Drug Targetor: a web interface to investigate the human druggome for over 500 phenotypes. Bioinformatics 2019 14(35):2515-2517.","DOI":"10.1093\/bioinformatics\/bty982"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.049"},{"key":"e_1_3_5_37_2","author":"Lample G.","year":"2016","unstructured":"Lample G., Ballesteros M., Subramanian S., Kawakami K. and Dyer C.: Neural Architec Named Entity Recogn 2016; .","journal-title":"Neural Architec Named Entity Recogn"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","unstructured":"Qi P Dozat T Zhang Y Manning CD. Universal Dependency Parsing from Scratch. 2019.","DOI":"10.18653\/v1\/K18-2016"},{"key":"e_1_3_5_39_2","article-title":"Disease Ontology: improving and unifying disease annotations across species","volume":"11","author":"Bello S.M.","year":"2018","unstructured":"Bello S.M., Shimoyama M., Mitraka E., Laulederkind S.J.F., Smith C.L., Eppig J.T. et al: Disease Ontology: improving and unifying disease annotations across species. Dis Model Mech 2018; 11: m32839.","journal-title":"Dis Model Mech"},{"key":"e_1_3_5_40_2","doi-asserted-by":"crossref","unstructured":"Yoshinobu I Noriyuki N Tomoya Y Atsushi O Yasuo O Tetsuro U Hiroshi Y. Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res 2015(D1):D921.","DOI":"10.1093\/nar\/gku955"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","first-page":"e102579","DOI":"10.1371\/journal.pone.0102579","article-title":"Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action","volume":"9","author":"Gusenleitner D.","year":"2014","unstructured":"Gusenleitner D., Auerbach S.S., Melia T., G\u00f3mez H.F., Sherr D.H., Monti S. et al: Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action. PLoS One 2014; 9: e102579.","journal-title":"PLoS One"},{"key":"e_1_3_5_42_2","unstructured":"Smyth GK Ritchie M Thorne N Wettenhall J Shi W. limma: Linear Models for Microarray Data. Bioinformatics & Computational Biology Solutions Using R & Bioconductor 2010."},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"e_1_3_5_44_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-018-0394-7","article-title":"Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates","volume":"10","author":"Vargas D.M.","year":"2018","unstructured":"Vargas D.M., De B., Zimmer E.R. and Klamt F.: Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates. Alzheimers Res Ther 2018; 10: 59.","journal-title":"Alzheimers Res Ther"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00208.2006"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/brain\/awl244","article-title":"Functions of the left superior frontal gyrus in humans: a lesion study","volume":"129","author":"Boisgueheneuc F.d.","year":"2006","unstructured":"Boisgueheneuc F.d., Levy R., Volle E., Seassau M., Duffau H., Kinkingnehun S. et al: Functions of the left superior frontal gyrus in humans: a lesion study. Brain 2006; 129: 3315.","journal-title":"Brain"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2017.04.024"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3978"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.12.044"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.conb.2017.05.018","article-title":"Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives","volume":"45","author":"Hollis F.","year":"2017","unstructured":"Hollis F., Kanellopoulos A.K. and Bagni C.: Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives. Curr Opin Neurobiol 2017; 45: 178.","journal-title":"Curr Opin Neurobiol"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2010.1706","article-title":"Mitochondrial dysfunction in autism","volume":"304","author":"Giulivi C.","year":"2010","unstructured":"Giulivi C., Zhang Y.-F., Omanska-Klusek A., Ross-Inta C., Wong S., Hertz-Picciotto I. et al: Mitochondrial dysfunction in autism. JAMA, J Am Med Assoc 2010; 304: 2389.","journal-title":"JAMA, J Am Med Assoc"},{"key":"e_1_3_5_52_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11011-013-9419-x","article-title":"Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain","volume":"28","author":"Guevara-Campos J.","year":"2013","unstructured":"Guevara-Campos J., Gonz\u00e1lez-Guevara L., Puig-Alcaraz C. and Cauli O.: Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain. Metab Brain Dis 2013; 28: 605.","journal-title":"Metab Brain Dis"},{"key":"e_1_3_5_53_2","unstructured":"Bharath SM. M. Post-Translational Oxidative Modifications of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase): Implications for Pathogenesis and Therapeutics in Human Diseases. J Alzheimers Dis 2017:1-18."},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","unstructured":"Chauhan A Gu F Essa MM Wegiel J Kaur K Brown WT Chauhan V: Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 2011 117(2):209-220.","DOI":"10.1111\/j.1471-4159.2011.07189.x"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bpa.12002","article-title":"Downregulation of the expression of mitochondrial electron transport complex genes in autism brains","volume":"23","author":"Anitha A.","year":"2013","unstructured":"Anitha A., Nakamura K., Thanseem I., Matsuzaki H., Miyachi T., Tsujii M. et al: Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol 2013; 23: 294.","journal-title":"Brain Pathol"},{"key":"e_1_3_5_56_2","unstructured":"Tripathi Lokesh P Prathipati Philip Mizuguchi Kenji Murakami Yoichi: Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery. Curr Opin Struc Biol 2017."},{"key":"e_1_3_5_57_2","article-title":"Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using \u2018In silico Pharmacology\u2018","volume":"15","author":"Zhu H.","year":"2014","unstructured":"Zhu H., Chen L., George P.D.C. and Chakraborty C.: Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using \u2018In silico Pharmacology\u2018. Curr Protein Pept Sci 2014; 15.","journal-title":"Curr Protein Pept Sci"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2012.06.003"},{"key":"e_1_3_5_59_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11203-y","article-title":"The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour","volume":"10","author":"Dom\u00ednguez-Iturza N.","year":"2019","unstructured":"Dom\u00ednguez-Iturza N., Lo A.C., Shah D., Armend\u00e1riz M., Vannelli A., Mercaldo V. et al: The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour. Nat Commun 2019; 10.","journal-title":"Nat Commun"},{"key":"e_1_3_5_60_2","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.273","article-title":"Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism","volume":"7","author":"Naaijen J.","year":"2017","unstructured":"Naaijen J., Bralten J., Poelmans G., Glennon J.C., Franke B., Buitelaar J.K., Ebstein R P. and Gill M.: Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism. Transl Psychiat 2017; 7. e999.","journal-title":"Transl Psychiat"},{"key":"e_1_3_5_61_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0488-4","article-title":"Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder","volume":"9","author":"Guan J.","year":"2019","unstructured":"Guan J., Cai J.J., Ji G. and Sham P.C.: Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder. Transl Psychiat 2019; 9.","journal-title":"Transl Psychiat"},{"key":"e_1_3_5_62_2","doi-asserted-by":"crossref","unstructured":"Penn R. Intrathecal baclofen for severe spinal spasticity Lancet 326(8447) 1985 125\u2013127.","DOI":"10.1016\/S0140-6736(85)90228-4"},{"key":"e_1_3_5_63_2","doi-asserted-by":"crossref","unstructured":"Mahdavinasab SM Saghazadeh A Motamed-Gorji N Vaseghi S Mohammadi MR Alichani R Akhondzadeh S: Baclofen as an adjuvant therapy for autism: a randomized double-blind placebo-controlled trial. Eur Child Adoles Psy 2019.","DOI":"10.1007\/s00787-019-01333-5"},{"key":"e_1_3_5_64_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/schbul\/sbp163","article-title":"Sulpiride augmentation for schizophrenia","volume":"36","author":"Wang J.","year":"2010","unstructured":"Wang J., Omori I.M., Fenton M. and Soares B.: Sulpiride augmentation for schizophrenia. Schizophrenia Bull 2010; 36: 229.","journal-title":"Schizophrenia Bull"},{"key":"e_1_3_5_65_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02211825","article-title":"Use of sulpiride in a case of atypical autism","volume":"18","author":"Scott D.W.","year":"1988","unstructured":"Scott D.W. and Eames P.: Use of sulpiride in a case of atypical autism. J Autism dev disord 1988; 18: 144.","journal-title":"J Autism dev disord"},{"key":"e_1_3_5_66_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nut.2015.10.019","article-title":"Abnormal fatty acids in Canadian children with autism","volume":"32","author":"Jory J.","year":"2016","unstructured":"Jory J.: Abnormal fatty acids in Canadian children with autism. Nutrition 2016; 32: 474.","journal-title":"Nutrition"},{"key":"e_1_3_5_67_2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pnpbp.2006.11.013","article-title":"The n-3 polyunsaturated fatty acid\/dopamine hypothesis of schizophrenia","volume":"31","author":"Ohara K.","year":"2007","unstructured":"Ohara K.: The n-3 polyunsaturated fatty acid\/dopamine hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 469.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2009.04.003"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6126"},{"key":"e_1_3_5_70_2","article-title":"Mechanistic evaluation of neuroprotective effect of estradiol on rotenone and 6-OHDA induced Parkinson's disease","author":"Dongfang S.","year":"2017","unstructured":"Dongfang S., Xiaoyan T., Binbin Z., Rongrong and Song : Mechanistic evaluation of neuroprotective effect of estradiol on rotenone and 6-OHDA induced Parkinson's disease. Pharmacol Rep Pr 2017; .","journal-title":"Pharmacol Rep Pr"},{"key":"e_1_3_5_71_2","unstructured":"Wenhao Yan Jun Wu Bo Song Qiang Luo Yuming Xu: Treatment with a brain-selective prodrug of 17\u03b2-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-\u03baB pathway. Naunyn Schmiedebergs Archives of Pharmacology 2019."},{"key":"e_1_3_5_72_2","doi-asserted-by":"crossref","unstructured":"Filice F Lauber E V Rckel KJ W Hr M Schwaller B: 17-\u03b2 estradiol increases parvalbumin levels in Pvalb heterozygous mice and attenuates behavioral phenotypes with relevance to autism core symptoms. Mol Autism 2018 9(1):15.","DOI":"10.1186\/s13229-018-0199-3"},{"key":"e_1_3_5_73_2","article-title":"Complex effects of 17\u03b2-estradiol on mitochondrial function","volume":"1817","author":"Thiede A.","year":"2012","unstructured":"Thiede A., Gellerich F., Sch\u00f6nfeld P. and Siemen D.: Complex effects of 17\u03b2-estradiol on mitochondrial function. BBA 2012; 1817.","journal-title":"BBA"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(86)90006-9"},{"key":"e_1_3_5_75_2","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-017-0147-7","article-title":"Hierarchical cortical transcriptome disorganization in autism","volume":"8","author":"Lombardo M.V.","year":"2017","unstructured":"Lombardo M.V., Courchesne E., Lewis N.E. and Pramparo T.: Hierarchical cortical transcriptome disorganization in autism. Mol Autism 2017; 8.","journal-title":"Mol Autism"},{"key":"e_1_3_5_76_2","first-page":"1","article-title":"Transcriptome of iPSC-derived neuronal cells reveals a module of co-expressed genes consistently associated with autism spectrum disorder","volume":"21","author":"Griesi-Oliveira K.","year":"2020","unstructured":"Griesi-Oliveira K., Fogo M.S., Pinto B.G.G., Alves A.Y. and Passos-Bueno M.R.: Transcriptome of iPSC-derived neuronal cells reveals a module of co-expressed genes consistently associated with autism spectrum disorder. Mol Psychiatr 2020; 21: 1.","journal-title":"Mol Psychiatr"},{"key":"e_1_3_5_77_2","article-title":"Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism","author":"Kaijie Q.","year":"2018","unstructured":"Kaijie Q., Luye M., Emmanuel D., Lara J., Liu A. and Yan : Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism. Neuropsychopharmacology 2018; .","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_5_78_2","first-page":"2016","article-title":"Beneficial effects of everolimus on autism and attention-deficit\/hyperactivity disorder symptoms in a group of patients with tuberous sclerosis complex","author":"Kilincaslan A.","year":"2016","unstructured":"Kilincaslan A., Kok B.E., Tekturk P., Yalcinkaya C., Ozkara C. and Yapici Z.: Beneficial effects of everolimus on autism and attention-deficit\/hyperactivity disorder symptoms in a group of patients with tuberous sclerosis complex. J Child Adol Psychop 2016; : 2016.","journal-title":"J Child Adol Psychop"},{"key":"e_1_3_5_79_2","first-page":"1","article-title":"Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan","volume":"41","author":"Mm A.","year":"2019","unstructured":"Mm A., Hi B., Ks C., Hyd E., Ys F., Ma G. et al: Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan. Brain Dev 2019; 41: 1.","journal-title":"Brain Dev"},{"key":"e_1_3_5_80_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.1996.01830110037005","article-title":"A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder","volume":"53","author":"Mcdougle C.J.","year":"1996","unstructured":"Mcdougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R. and Price L.H.: A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996; 53: 1001.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_5_81_2","first-page":"314","article-title":"Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder","volume":"33","author":"Fukuda T.","year":"2001","unstructured":"Fukuda T., Sugie H., Ito M. and Sugie Y.: Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder. No to Hattatsu Brain Dev 2001; 33: 314.","journal-title":"No to Hattatsu Brain Dev"},{"key":"e_1_3_5_82_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2015.09.012","article-title":"Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders","author":"Bhandari R.","year":"2015","unstructured":"Bhandari R. and Kuhad A.: Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sci 2015; .","journal-title":"Life Sci"},{"key":"e_1_3_5_83_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainresbull.2017.11.011","article-title":"The Kv7\/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease","volume":"137","author":"Liu H.","year":"2018","unstructured":"Liu H., Jia L., Chen X., Shi L. and Xie J.: The Kv7\/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease. Brain Res Bull 2018; 137: 132.","journal-title":"Brain Res Bull"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.20717"},{"key":"e_1_3_5_85_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.expneurol.2019.01.017","article-title":"Experimental traumatic brain injury results in estrous cycle disruption, neurobehavioral deficits, and impaired GSK3\u03b2\/\u03b2-catenin signaling in females","volume":"315","author":"Fortress A.M.","year":"2019","unstructured":"Fortress A.M., Avcu P., Wagner A.K., Dixon C.E. and Pang K.C.H.: Experimental traumatic brain injury results in estrous cycle disruption, neurobehavioral deficits, and impaired GSK3\u03b2\/\u03b2-catenin signaling in females. Exp Neurol 2019; 315: 42.","journal-title":"Exp Neurol"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2213"},{"key":"e_1_3_5_87_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-016-0391-4","article-title":"Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity","volume":"16","author":"Qasem H.","year":"2017","unstructured":"Qasem H., Alayadhi L. and Dera H.A.: Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity. Lipids Health Dis 2017; 16: 117.","journal-title":"Lipids Health Dis"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021002841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021002841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.06.046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:48:24Z","timestamp":1779022104000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.06.046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":86,"alternative-id":["10.1016\/j.csbj.2021.06.046"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.06.046","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}